Found: 4
Select item for more details and to access through your institution.
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0277-6
- By:
- Publication type:
- Article
Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1165, doi. 10.1111/bjh.16463
- By:
- Publication type:
- Article
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 356, doi. 10.1111/bjh.16088
- By:
- Publication type:
- Article
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 242, doi. 10.1111/bjh.15560
- By:
- Publication type:
- Article